Skip directly to Accessibility Notice

Health Care and Tech Stocks Weigh on Moat Index

14 September 2021

 

The Morningstar® Wide Moat Focus IndexSM (the “Moat Index” or “Index”) underperformed the S&P 500® Index in August (1.43% vs. 3.04%, respectively). The final month of summer marked the third consecutive month the Index lagged the S&P 500 Index, but it remained ahead by 2.5% year to date through August (24.47% vs. 21.95%, respectively).

As is typically the case, the Moat Index’s relative performance was influenced predominantly by stock selection and its selection within the health care and information technology sectors was the most influential for the period.

Aspen Technology: Revenue Miss, But Moat Stock Remains on Solid Footing

Aspen Technology (AZPN) provides automation solutions to customers in complex industrial environments, lending to Aspens’ high customer switching costs that support its wide moat rating from Morningstar. Aspen reported a decline in quarterly revenue in mid-August and its shares sold off rapidly thereafter.

While some customer segments, such as refining and chemicals saw signs of life, others remain in a subdued demand environment, and management projected a back-end loaded 2022, according to Morningstar.

Despite near-term hurdles, Morningstar increased Aspen’s fair value estimate in August from $145 per share to $151 and remains confident in the underlying value and applicability of Aspen’s solutions, as is reflected in Aspen’s full pipeline and continuing and increasing customer engagement. Shares of Aspen finished August at a 14% discount to its fair value estimate, according to Morningstar.

Zimmer Biomet: Health Care Moat Company Lingers in Waiting Room

Zimmer Biomet (ZBH) is a medical device company specializing in the implants used in large joint reconstruction. Because the extensive instrumentation, or tool sets, used to prepare bones and install implants are specific to each company, there are significant switching costs applicable to an orthopedic surgeon when choosing a new device manufacturer. Not only can the process be costly and time consuming for the surgeon, there is reputational risk at stake when learning a new process or procedure related to surgery. This switching cost is the primary driver Morningstar attributes to Zimmer Biomet’s wide economic moat.

The firm reported somewhat disappointing second quarter results at the beginning of August. Management attributed this to the unevenness of large joint replacement patients returning for treatment following a prolonged period of postponed elective medical procedures in the U.S. Morningstar was uncertain about this line from Zimmer Biomet’s management, as rival wide moat firm, Stryker Corp., was apparently not impacted by such trends.

Nonetheless, Morningstar did not see anything to suggest Zimmer Biomet’s wide moat was impaired in any way and left its fair value estimate in place pointing to a 20% discount to fair value for shares at the end of August.

Diagnosis Not all Bad in Health Care and Tech Moat Stocks

Ironically, the leading contributors to Moat Index returns in August were also from the health care and information technology sectors. These companies, which included ServiceNow, Salesforce.com, Alphabet Inc., Pfizer and Facebook, among others, were not enough to overcome other detractors for the month when compared to the S&P 500 Index.

Morningstar Wide Moat Focus Index Leaders and Laggards – August 2021

Leading Contributors to Return

Company Ticker Sector Contribution (%)
ServiceNow Inc. NOW Information Technology 0.28
Salesforce.com Inc. CRM Information Technology 0.24
Alphabet Inc. GOOGL Communication Services 0.21
Pfizer Inc. PFE Health Care 0.20
Facebook Inc. FB Information Technology 0.17

Leading Detractors from Return

Company Ticker Sector Contribution (%)
Aspen Technology AZPN Information Technology -0.27
Zimmer Biomet Holdings Inc. ZBH Health Care -0.19
Cerner Corp. CERN Health Care -0.12
Constellation Brands Inc. STZ Consumer Staples -0.12
Polaris Inc. PII Consumer Discretionary -0.11

Source: Morningstar. Past performance is no guarantee of future results. Individual company and index performance is not illustrative of fund performance. For fund performance current to the most recent month-end, visit vaneck.com.

VanEck Morningstar US Wide Moat UCITS ETF (MOAT) seeks to replicate as closely as possible, before fees and expenses the price and yield performance of the Morningstar Wide Moat Focus Index.

Important Disclosure

This is a marketing communication. Please refer to the prospectus of the UCITS and to the KID before making any final investment decisions.

This information originates from VanEck (Europe) GmbH, which has been appointed as distributor of VanEck products in Europe by the Management Company VanEck Asset Management B.V., incorporated under Dutch law and registered with the Dutch Authority for the Financial Markets (AFM). VanEck (Europe) GmbH with registered address at Kreuznacher Str. 30, 60486 Frankfurt, Germany, is a financial services provider regulated by the Federal Financial Supervisory Authority in Germany (BaFin).

The information is intended only to provide general and preliminary information to investors and shall not be construed as investment, legal or tax advice VanEck (Europe) GmbH, VanEck Switzerland AG, VanEck Securities UK Limited and their associated and affiliated companies (together “VanEck”) assume no liability with regards to any investment, divestment or retention decision taken by the investor on the basis of this information. The views and opinions expressed are those of the author(s) but not necessarily those of VanEck. Opinions are current as of the publication date and are subject to change with market conditions. Certain statements contained herein may constitute projections, forecasts and other forward-looking statements, which do not reflect actual results. Information provided by third party sources is believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. Brokerage or transaction fees may apply.

VanEck Asset Management B.V., the management company of VanEck Morningstar US Sustainable Wide Moat UCITS ETF (the "ETF"), a sub-fund of VanEck UCITS ETFs plc, is a UCITS management company under Dutch law registered with the Dutch Authority for the Financial Markets (AFM). The ETF is registered with the Central Bank of Ireland, passively managed and tracks an equity index. Investing in the ETF should be interpreted as acquiring shares of the ETF and not the underlying assets. Investors must read the sales prospectus and key investor information before investing in a fund. These are available in English and the KIIDs/KIDs in certain other languages as applicable and can be obtained free of charge at www.vaneck.com, from the Management Company or from the following local information agents:
UK - Facilities Agent: Computershare Investor Services PLC
Austria - Facility Agent: Erste Bank der oesterreichischen Sparkassen AG
Germany - Facility Agent: VanEck (Europe) GmbH
Spain - Facility Agent: VanEck (Europe) GmbH
Sweden - Paying Agent: Skandinaviska Enskilda Banken AB (publ)
France - Facility Agent: VanEck (Europe) GmbH
Portugal - Paying Agent: BEST – Banco Eletrónico de Serviço Total, S.A.
Luxembourg - Facility Agent: VanEck (Europe) GmbH

Morningstar® US Sustainability Moat Focus Index is a trade mark of Morningstar Inc. and has been licensed for use for certain purposes by VanEck. VanEck Morningstar US Sustainable Wide Moat UCITS ETF is not sponsored, endorsed, sold or promoted by Morningstar and Morningstar makes no representation regarding the advisability in VanEck Morningstar US Sustainable Wide Moat UCITS ETF.
Effective December 17, 2021 the Morningstar® Wide Moat Focus IndexTM has been replaced with the Morningstar® US Sustainability Moat Focus Index.
Effective June 20, 2016, Morningstar implemented several changes to the Morningstar Wide Moat Focus Index construction rules. Among other changes, the index increased its constituent count from 20 stocks to at least 40 stocks and modified its rebalance and reconstitution methodology. These changes may result in more diversified exposure, lower turnover and longer holding periods for index constituents than under the rules in effect prior to this date.
It is not possible to invest directly in an index.

All performance information is based on historical data and does not predict future returns. Investing is subject to risk, including the possible loss of principal.

No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission of VanEck.

© VanEck (Europe) GmbH / VanEck Asset Management B.V.

1 - 3 of 3